Brief: Proqr Therapeutics Completes Transaction For Théa To Acquire Sepofarsen And Ultevursen Ophthalmic Assets

ProQR Therapeutics NV

08/12/2023 13:32

Dec 8 (Reuters) - ProQR Therapeutics NV  PRQR.O :
    * PROQR THERAPEUTICS ANNOUNCES TRANSACTION COMPLETED FOR
THÉA TO
ACQUIRE SEPOFARSEN AND ULTEVURSEN OPHTHALMIC ASSETS
    * PROQR THERAPEUTICS NV - AGREEMENT PROVIDES PROQR WITH
INITIAL
PAYMENT OF EUR 8M AND UP TO EUR 165M IN EARN-OUT PAYMENTS
    * PROQR THERAPEUTICS NV - AGREEMENT PROVIDES AGREEMENT
PROVIDES
PROQR WITH POTENTIAL DOUBLE-DIGIT ROYALTIES BASED ON COMMERCIAL
SALES IN US AND EU

Source text for Eikon:  ID:nGNX6QXrvy 
Further company coverage:  PRQR.O 

 ((reuters.briefs@thomsonreuters.com;))